LD-2 disclosure · 4th Quarter - Report
INFUSION PROVIDERS ALLIANCE
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Healthcare Association
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
LobbyistsBRAD TRAVERSE
Covered position (BRAD TRAVERSE): Former Senior Advisor, Office of the HHS Assistant Secretary of Public Affairs
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS) · Medicare Payment Advisory Commission (MedPAC)
Health Issues
None
LobbyistsBRAD TRAVERSE